Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Payables (2016 - 2025)

STRATA Skin Sciences' Payables history spans 14 years, with the latest figure at $3.0 million for Q3 2025.

  • For Q3 2025, Payables rose 68.95% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, up 68.95%, while the annual FY2024 figure was $2.4 million, 27.22% down from the prior year.
  • Payables for Q3 2025 was $3.0 million at STRATA Skin Sciences, roughly flat from $2.9 million in the prior quarter.
  • Across five years, Payables topped out at $10.4 million in Q1 2021 and bottomed at $1.7 million in Q3 2024.
  • The 5-year median for Payables is $3.2 million (2023), against an average of $3.9 million.
  • The largest annual shift saw Payables tumbled 76.96% in 2021 before it surged 76.17% in 2022.
  • A 5-year view of Payables shows it stood at $2.8 million in 2021, then increased by 21.37% to $3.4 million in 2022, then fell by 2.39% to $3.3 million in 2023, then decreased by 27.22% to $2.4 million in 2024, then grew by 21.45% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Payables are $3.0 million (Q3 2025), $2.9 million (Q2 2025), and $2.8 million (Q1 2025).